Paper39770531
Small Molecules in Parkinson's Disease Therapy: From Dopamine Pathways to New Emerging Targets.
Lee H and 6 others. Pharmaceuticals (Basel), 2024. Cited by 14 papers, by iCite.
Cite this record
ConductScience Library. Small Molecules in Parkinson's Disease Therapy: From Dopamine Pathways to New Emerging Targets. Papers, record 39770531. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39770531
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Small Molecules in Parkinson's Disease Therapy: From Dopamine Pathways to New Emerging Targets.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References106
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 27486710 | Genetics of Parkinson's disease: a review of SNCA and LRRK2. | Wiad Lek | 2016 | https://conductscience.org/library/papers/27486710 | PubMed |
| 2 | 32584021 | General Aggregation-Induced Emission Probes for Amyloid Inhibitors with Dual Inhibition Capacity against Amyloid β-Protein and α-Synuclein. | ACS Appl Mater Interfaces | 2020 | https://conductscience.org/library/papers/32584021 | PubMed |
| 3 | 33432241 | Reverse engineering Lewy bodies: how far have we come and how far can we go? | Nat Rev Neurosci | 2021 | https://conductscience.org/library/papers/33432241 | PubMed |
| 4 | 11701750 | Adenosine in the central nervous system: release mechanisms and extracellular concentrations. | J Neurochem | 2001 | https://conductscience.org/library/papers/11701750 | PubMed |
| 5 | 24354345 | Discovery of highly potent, selective, and brain-penetrant aminopyrazole leucine-rich repeat kinase 2 (LRRK2) small molecule inhibitors. | J Med Chem | 2014 | https://conductscience.org/library/papers/24354345 | PubMed |
| 6 | 24756517 | Pharmacological treatment of Parkinson disease: a review. | JAMA | 2014 | https://conductscience.org/library/papers/24756517 | PubMed |
| 7 | 21724302 | Dopaminergic agonists in Parkinson's disease. | Neurologia | 2014 | https://conductscience.org/library/papers/21724302 | PubMed |
| 8 | 28353284 | Models of LRRK2-Associated Parkinson's Disease. | Adv Neurobiol | 2017 | https://conductscience.org/library/papers/28353284 | PubMed |
| 9 | 20082977 | Dissecting the potential molecular mechanisms underlying alpha-synuclein cell-to-cell transfer in Parkinson's disease. | Parkinsonism Relat Disord | 2009 | https://conductscience.org/library/papers/20082977 | PubMed |
| 10 | 37312864 | Novel C-Linked Isoquinoline Amides as LRRK2 Inhibitors for Treating Parkinson's Disease. | ACS Med Chem Lett | 2023 | https://conductscience.org/library/papers/37312864 | PubMed |
| 11 | 30160213 | Different Generations of Type-B Monoamine Oxidase Inhibitors in Parkinson's Disease: From Bench to Bedside. | Curr Neuropharmacol | 2019 | https://conductscience.org/library/papers/30160213 | PubMed |
| 12 | 30982161 | Targeting α-Synuclein in Parkinson's Disease: Progress Towards the Development of Disease-Modifying Therapeutics. | Drugs | 2019 | https://conductscience.org/library/papers/30982161 | PubMed |
| 13 | 33197196 | Selective Inhibitors of G2019S-LRRK2 Kinase Activity. | J Med Chem | 2020 | https://conductscience.org/library/papers/33197196 | PubMed |
| 14 | 33219714 | The Role of Cholesterol in α-Synuclein and Lewy Body Pathology in GBA1 Parkinson's Disease. | Mov Disord | 2021 | https://conductscience.org/library/papers/33219714 | PubMed |
| 15 | 35455941 | GBA Variants and Parkinson Disease: Mechanisms and Treatments. | Cells | 2022 | https://conductscience.org/library/papers/35455941 | PubMed |
| 16 | 16944356 | Ergoline and non-ergoline derivatives in the treatment of Parkinson's disease. | J Neurol | 2006 | https://conductscience.org/library/papers/16944356 | PubMed |
| 17 | 33721670 | Developing novel classes of protein kinase CK1δ inhibitors by fusing [1,2,4]triazole with different bicyclic heteroaromatic systems. | Eur J Med Chem | 2021 | https://conductscience.org/library/papers/33721670 | PubMed |
| 18 | 37147404 | Parkinson's disease therapy: what lies ahead? | J Neural Transm (Vienna) | 2023 | https://conductscience.org/library/papers/37147404 | PubMed |
| 19 | 35675433 | Preclinical and clinical evaluation of the LRRK2 inhibitor DNL201 for Parkinson's disease. | Sci Transl Med | 2022 | https://conductscience.org/library/papers/35675433 | PubMed |
| 20 | 30023743 | Biological and Pharmacological Characterization of Benzothiazole-Based CK-1δ Inhibitors in Models of Parkinson's Disease. | ACS Omega | 2017 | https://conductscience.org/library/papers/30023743 | PubMed |
Cited by13
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 14 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42890068 | Integrated Experimental and Computational Investigation of Fluorinated Benzoylthiourea Derivatives: Structural Characterization, Hirshfeld Surface Analysis, Antioxidant Activity, and MAO-B Inhibitory Potential for Parkinson's Disease. | ACS Omega | 2026 | https://conductscience.org/library/papers/42890068 | PubMed |
| 42879042 | β-Cyclodextrin-Complexed 1,8-Cineole Attenuates Motor Deficits and Preserves Tyrosine Hydroxylase Immunoreactivity in a Reserpine-Induced Mouse Model of Parkinsonism. | Mol Neurobiol | 2026 | https://conductscience.org/library/papers/42879042 | PubMed |
| 42451623 | Bioanalytical HPLC-UV Determination of Dopamine in Plasma and Mouse Brain Homogenate with Greenness, Whiteness, and Blueness Assessment. | Molecules | 2026 | https://conductscience.org/library/papers/42451623 | PubMed |
| 42193194 | Overcoming Oxidative Stress in Parkinson's Disease: NADPH Oxidase 4 (NOX4) as a Potential Therapeutic Target. | Antioxidants (Basel) | 2026 | https://conductscience.org/library/papers/42193194 | PubMed |
| 41991085 | DYRK1A and Parkinson's disease, facts and hypotheses. | Neurobiol Dis | 2026 | https://conductscience.org/library/papers/41991085 | PubMed |
| 41516146 | Dopamine and the Gut Microbiota: Interactions Within the Microbiota-Gut-Brain Axis and Therapeutic Perspectives. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41516146 | PubMed |
| 41462616 | MQPD: An Antioxidant Quinone-Dopamine Hybrid Which Induces Sustained Brain Dopamine Elevation. | Antioxidants (Basel) | 2025 | https://conductscience.org/library/papers/41462616 | PubMed |
| 41153773 | Exploring Cannabidiol's Role in Regenerative Medicine: Focus on Neural and Skeletal Tissues. | Biomedicines | 2025 | https://conductscience.org/library/papers/41153773 | PubMed |
| 41097126 | Lactiplantibacillus plantarum as a Psychobiotic Strategy Targeting Parkinson's Disease: A Review and Mechanistic Insights. | Nutrients | 2025 | https://conductscience.org/library/papers/41097126 | PubMed |
| 41017678 | Immune dysregulation and gut microbiota: Connection to health and disease development. | Neural Regen Res | 2026 | https://conductscience.org/library/papers/41017678 | PubMed |
| 40808332 | Levodopa and Plant-Derived Bioactive Compounds in Parkinson's Disease: Mechanisms, Efficacy, and Future Perspectives. | CNS Neurosci Ther | 2025 | https://conductscience.org/library/papers/40808332 | PubMed |
| 40564183 | Next-Generation Drug Delivery for Neurotherapeutics: The Promise of Stimuli-Triggered Nanocarriers. | Biomedicines | 2025 | https://conductscience.org/library/papers/40564183 | PubMed |
| 40255917 | Dysregulation of Astrocytic ATP/Adenosine Release in the Hippocampus Cause Cognitive and Affective Disorders: Molecular Mechanisms, Diagnosis, and Therapy. | MedComm (2020) | 2025 | https://conductscience.org/library/papers/40255917 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| SNCA | 6622 | PubTator's text mining | https://conductscience.org/library/genes/6622 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39770531
GET https://conductscience.org/api/papers/v1/39770531/references?page=2